{"@context": "https://schema.org", "@type": "BreadcrumbList", "itemListElement": [{"@type": "ListItem", "position": 1, "name": "Home", "item": "https://www.patentleaderboard.com/"}, {"@type": "ListItem", "position": 2, "name": "2021", "item": "https://www.patentleaderboard.com/2021/"}, {"@type": "ListItem", "position": 3, "name": "Genzyme", "item": "https://www.patentleaderboard.com/2021/company/genzyme"}, {"@type": "ListItem", "position": 4, "name": "Marco A. Passini", "item": "https://www.patentleaderboard.com/2021/inventor/fl:ma_ln:passini-1"}]}
Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
MP

Marco A. Passini — 4 Patents in 2021

STSarepta Therapeutics: 3 patents #2 of 20Top 10%
GEGenzyme: 1 patents #20 of 122Top 20%
Cambridge, MA: #115 of 1,823 inventorsTop 7%
Massachusetts: #867 of 14,123 inventorsTop 7%
Overall (2021): #44,459 of 548,734Top 9%
4 Patents 2021

Issued Patents 2021

Showing 1–4 of 4 patents

Patent #TitleCo-InventorsDateApprox Value ⓘ
11000600 Exon skipping oligomer conjugates for muscular dystrophy Gunnar J. Hanson 2021-05-11 $92,984,000
10913956 Gene therapy for neurometabolic disorders Greg Stewart, James Dodge 2021-02-09
10905709 Modified antisense oligomers for exon inclusion in spinal muscular atrophy Gunnar J. Hanson 2021-02-02 $39,029,000
10888578 Exon skipping oligomer conjugates for muscular dystrophy Gunnar J. Hanson 2021-01-12 $113,442,000